{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T08:13:29Z","timestamp":1794903209992,"version":"4.9.1"},"reference-count":33,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["HSS Journal\u00ae: The Musculoskeletal Journal of Hospital for Special Surgery"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce surgical risks through metabolic and anti-inflammatory benefits, but their evidence in spine surgery remains mixed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>We sought to compare postoperative outcomes and healthcare use after lumbar discectomy between GLP-1 RA users and 2 control cohorts: obese and normal body mass index (BMI) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Adults with lumbar disk herniation undergoing single-level discectomy (2010-2023) were identified in the PearlDiver database. Three cohorts were created: (1) GLP-1 RA users (N\u2009=\u2009540); (2) obese controls (N\u2009=\u200963\u2009445); and (3) normal-BMI controls (N\u2009=\u200996,965). After propensity score matching (PSM), 539 GLP-1 RA users were matched with 539 obese controls on age, sex, Charlson Comorbidity Index (CCI), diabetes mellitus, and tobacco use. Two-tailed\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -tests and \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      tests were performed for pairwise comparisons between unmatched and matched GLP-1 RA users and obese controls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Compared to obese controls, GLP-1 RA users demonstrated lower rates of 90-day medical complications, such as pneumonia, that persisted after PSM, and lower rates of 90-day emergency department visits before and after PSM. In addition, GLP-1 RA users demonstrated lower rates of hospital readmissions compared to obese controls, before and after PSM. GLP-1 RA users incurred higher total 90-day costs, but this did not persist after PSM. While GLP-1 RA users had higher 2-year revision discectomy rates than matched obese controls (4.1% vs 2.4%), this difference was not statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>After PSM on demographics and select comorbidities, preoperative GLP-1 RA exposure was associated with lower 90-day medical complications, unplanned ED visits, and readmissions following single-level lumbar discectomy compared to obese controls. Revision discectomy and lumbar fusion rates were not significantly different after matching. Future research is needed to guide perioperative management of GLP-1 RA medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>Level III, Retrospective comparative cohort study<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/15563316261455872","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T11:13:26Z","timestamp":1780744406000},"page":"370-377","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Lumbar Discectomy Outcomes and Preoperative Glucagon-like Peptide-1 Receptor Agonist Exposure: A Retrospective, Comparative Cohort Study"],"prefix":"10.1177","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1645-5750","authenticated-orcid":false,"given":"Joyce En-Hua","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Virginia Health System, Charlottesville, VA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3715-5422","authenticated-orcid":false,"given":"Madeline","family":"Phillips","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Virginia School of Medicine, Charlottesville, VA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidushan","family":"Nadarajah","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Virginia Health System, Charlottesville, VA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Lockey","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Virginia Health System, Charlottesville, VA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","unstructured":"Jain D Berven S. Effect of obesity on the development management and outcomes of spinal disorders. J Am Acad Orthop Surg. 2019;27(11):e499-e506. https:\/\/doi.org\/10.5435\/JAAOS-D-17-00837","DOI":"10.5435\/JAAOS-D-17-00837"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","unstructured":"Segar AH Baroncini A Urban JPG Fairbank J Judge A McCall I. Obesity increases the odds of intervertebral disc herniation and spinal stenosis; an MRI study of 1634 low back pain patients. Eur Spine J. 2024;33(3):915-923. https:\/\/doi.org\/10.1007\/s00586-024-08154-4","DOI":"10.1007\/s00586-024-08154-4"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","unstructured":"Coppock JA Danyluk ST Englander ZA Spritzer CE Goode AP DeFrate LE. Increasing BMI increases lumbar intervertebral disc deformation following a treadmill walking stress test. J Biomech. 2021;121:110392. https:\/\/doi.org\/10.1016\/j.jbiomech.2021.110392","DOI":"10.1016\/j.jbiomech.2021.110392"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","unstructured":"Shiri R Lallukka T Karppinen J Viikari-Juntura E. Obesity as a risk factor for sciatica: a meta-analysis. Am J Epidemiol. 2014;179(8):929-937. https:\/\/doi.org\/10.1093\/aje\/kwu007","DOI":"10.1093\/aje\/kwu007"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","unstructured":"Varshneya K Wadhwa H Stienen MN et al. Obesity in patients undergoing lumbar degenerative surgery-A retrospective cohort study of postoperative outcomes. Spine (Phila Pa 1976). 2021;46(17):1191-1196. https:\/\/doi.org\/10.1097\/BRS.0000000000004001","DOI":"10.1097\/BRS.0000000000004001"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","unstructured":"Rihn JA Kurd M Hilibrand AS et al. The influence of obesity on the outcome of treatment of lumbar disc herniation: analysis of the Spine Patient Outcomes Research Trial (SPORT). J Bone Joint Surg Am. 2013;95(1):1-8. https:\/\/doi.org\/10.2106\/JBJS.K.01558","DOI":"10.2106\/JBJS.K.01558"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","unstructured":"McGuire KJ Khaleel MA Rihn JA Lurie JD Zhao W Weinstein JN. The effect of high obesity on outcomes of treatment for lumbar spinal conditions: subgroup analysis of the spine patient outcomes research trial. Spine (Phila Pa 1976). 2014;39(23):1975-1980. https:\/\/doi.org\/10.1097\/brs.0000000000000577","DOI":"10.1097\/BRS.0000000000000577"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","unstructured":"Bohl DD Ahn J Mayo BC et al. Does greater body mass index increase the risk for revision procedures following a single-level minimally invasive lumbar discectomy? Spine (Phila Pa 1976). 2016;41(9):816-821. https:\/\/doi.org\/10.1097\/BRS.0000000000001340","DOI":"10.1097\/BRS.0000000000001340"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","unstructured":"Harrop JS Mohamed B Bisson EF et al. Congress of neurological surgeons systematic review and evidence-based guidelines for perioperative spine: preoperative surgical risk assessment: preoperative surgical risk assessment. Neurosurgery. 2021;89(Suppl 1):S9-S18. https:\/\/doi.org\/10.1093\/neuros\/nyab316","DOI":"10.1093\/neuros\/nyab316"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","unstructured":"Celletti F Farrar J De Regil L. World Health Organization guideline on the use and indications of glucagon-like peptide-1 therapies for the treatment of obesity in adults. JAMA. Published online December 1 2025. https:\/\/doi.org\/10.1001\/jama.2025.24288","DOI":"10.1001\/jama.2025.24288"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","unstructured":"Wong CK Drucker DJ. Antiinflammatory actions of glucagon-like peptide-1\u2013based therapies beyond metabolic benefits. J Clin Inves. 2025;135(21):e194751. https:\/\/doi.org\/10.1172\/JCI194751","DOI":"10.1172\/JCI194751"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","unstructured":"Madsbad S Holst JJ. Cardiovascular effects of incretins: focus on glucagon-like peptide-1 receptor agonists. Cardiovasc Res. 2023;119(4):886-904. https:\/\/doi.org\/10.1093\/cvr\/cvac112","DOI":"10.1093\/cvr\/cvac112"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","unstructured":"Kamarajah SK Gudiozzi N Findlay JM Lee MJ Pinkney T Markar SR. Evaluation of safety of preoperative GLP-1 receptor agonists in patients undergoing elective surgery: a systematic review meta-analysis and meta-regression. eClinicalMedicine. 2025;87:103408. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103408","DOI":"10.1016\/j.eclinm.2025.103408"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","unstructured":"Lee S Singh K Clark SC Goh GS. The impact of glucagon-like peptide-1 receptor agonist use on clinical outcomes after total hip and knee arthroplasty: a systematic review and meta-analysis of 346 899 patients. J Arthroplasty. Published online October 8 2025. https:\/\/doi.org\/10.1016\/j.arth.2025.09.054","DOI":"10.1016\/j.arth.2025.09.054"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","unstructured":"Barkyoumb D Muhammad F Smith ZA Shakir HJ. Preoperative optimization of obese spine patients with GLP-1 receptor agonists: enhancing surgery and improving outcomes. J Spine Surg. 2025;11(2):339-346. https:\/\/doi.org\/10.21037\/jss-24-152","DOI":"10.21037\/jss-24-152"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","unstructured":"Younus I Garcia de Oliveira R Fujii T et al. Are GLP-1 receptor agonists safe in spine surgery: a systematic review. Spine (Phila Pa 1976). Published online July 28 2025. https:\/\/doi.org\/10.1097\/BRS.0000000000005466","DOI":"10.1097\/BRS.0000000000005466"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","unstructured":"Chang MG Ripoll JG Lopez E Krishnan K Bittner EA. A scoping review of GLP-1 receptor agonists: are they associated with increased gastric contents regurgitation and aspiration events? J Clin Med. 2024;13(21):6336. https:\/\/doi.org\/10.3390\/jcm13216336","DOI":"10.3390\/jcm13216336"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","unstructured":"do Nascimento TS Pereira ROL Maia E et al. The impact of glucagon-like peptide-1 receptor agonists in the patients undergoing anesthesia or sedation: systematic review and meta-analysis. Perioper Med (Lond). 2024;13(1):78. https:\/\/doi.org\/10.1186\/s13741-024-00439-y","DOI":"10.1186\/s13741-024-00439-y"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","unstructured":"Yagi M Fujita N Okada E et al. Impact of frailty and comorbidities on surgical outcomes and complications in adult spinal disorders. Spine (Phila Pa 1976). 2018;43(18):1259-1267. https:\/\/doi.org\/10.1097\/BRS.0000000000002596","DOI":"10.1097\/BRS.0000000000002596"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","unstructured":"Voskuijl T Hageman M Ring D. Higher Charlson Comorbidity Index Scores are associated with readmission after orthopaedic surgery. Clin Orthop Relat Res. 2014;472(5):1638-1644. https:\/\/doi.org\/10.1007\/s11999-013-3394-8","DOI":"10.1007\/s11999-013-3394-8"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","unstructured":"Saberi H Rahimi L Jahani L. A comparative MRI study of upper and lower lumbar motion segments in patients with low back pain. J Spinal Disord Tech. 2009;22(7):507-510. https:\/\/doi.org\/10.1097\/BSD.0b013e3181927051","DOI":"10.1097\/BSD.0b013e3181927051"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","unstructured":"Emerson PC Wakelin SH Zhao DY et al. Radiologic and patient-derived predictors for recurrent lumbar disc herniation after minimally invasive tubular discectomy: a single-center analysis of 404 patients. World Neurosurg. 2025;200:124192. https:\/\/doi.org\/10.1016\/j.wneu.2025.124192","DOI":"10.1016\/j.wneu.2025.124192"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","unstructured":"Chan AK Letchuman V Mummaneni PV et al. Inferior clinical outcomes for patients with Medicaid insurance after surgery for degenerative lumbar spondylolisthesis: a prospective registry analysis of 608 patients. World Neurosurg. 2022;164:e1024-e1033. https:\/\/doi.org\/10.1016\/j.wneu.2022.05.094","DOI":"10.1016\/j.wneu.2022.05.094"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","unstructured":"Shin D Razzouk J Thomas J et al. Social determinants of health and disparities in spine surgery: a 10-year analysis of 8 565 cases using ensemble machine learning and multilayer perceptron. Spine J. 2025;25(10):2236-2252. https:\/\/doi.org\/10.1016\/j.spinee.2024.07.003","DOI":"10.1016\/j.spinee.2024.07.003"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","unstructured":"Bolognesi MP Habermann EB. Commercial claims data sources: PearlDiver and individual payer databases. J Bone Joint Surg Am. 2022;104(Suppl 3):15-17. https:\/\/doi.org\/10.2106\/JBJS.22.00607","DOI":"10.2106\/JBJS.22.00607"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","unstructured":"Park C Garcia AN Cook C Shaffrey CI Gottfried ON. Long-term impact of obesity on patient-reported outcomes and patient satisfaction after lumbar spine surgery: an observational study. J Neurosurg Spine. 2021;34(1):73-82. https:\/\/doi.org\/10.3171\/2020.6.spine20592","DOI":"10.3171\/2020.6.SPINE20592"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","unstructured":"Tetlow N Whittle J. Prehabilitation: do we need metabolic flexibility? Ann Nutr Metab. 2025;81(4):223-233. https:\/\/doi.org\/10.1159\/000545266","DOI":"10.1159\/000545266"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","unstructured":"Yao H Zhang A Li D et al. Comparative effectiveness of GLP-1 receptor agonists on glycaemic control body weight and lipid profile for type 2 diabetes: systematic review and network meta-analysis. BMJ. 2024;384:e076410. https:\/\/doi.org\/10.1136\/bmj-2023-076410","DOI":"10.1136\/bmj-2023-076410"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","unstructured":"Hagve M Gjessing PF Hole MJ et al. Perioperative infusion of glucagon-like peptide-1 prevents insulin resistance after surgical trauma in female pigs. Endocrinology. 2019;160(12):2892-2902. https:\/\/doi.org\/10.1210\/en.2019-00374","DOI":"10.1210\/en.2019-00374"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","unstructured":"Pennington Z Lubelski D Westbroek EM Ahmed AK Passias PG Sciubba DM. Persistent postoperative hyperglycemia as a risk factor for operative treatment of deep wound infection after spine surgery. Neurosurgery. 2020;87(2):211-219. https:\/\/doi.org\/10.1093\/neuros\/nyz405","DOI":"10.1093\/neuros\/nyz405"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","unstructured":"Kim MT Lee S Goh GS Riew KD. Perioperative GLP-1 receptor agonist use is associated with reduced revisions and complications following ACDF: a propensity-matched analysis. Global Spine J. Published online January 29 2026. https:\/\/doi.org\/10.1177\/21925682261419753","DOI":"10.1177\/21925682261419753"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","unstructured":"Mai Z Kornak J Dufault SM Strand MW Reikes AR Watanabe JH. Association of baseline comorbidities with first-year adherence to GLP-1 receptor agonists in patients with diabetes or obesity: a retrospective cohort study. Ann Pharmacother. Published online December 7 2025. https:\/\/doi.org\/10.1177\/10600280251384637","DOI":"10.1177\/10600280251384637"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","unstructured":"Cella D Riley W Stone A et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010;63(11):1179-1194. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.011","DOI":"10.1016\/j.jclinepi.2010.04.011"}],"container-title":["HSS Journal\u00ae: The Musculoskeletal Journal of Hospital for Special Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15563316261455872","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15563316261455872","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15563316261455872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:17:16Z","timestamp":1783495036000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15563316261455872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1177\/15563316261455872"],"URL":"https:\/\/doi.org\/10.1177\/15563316261455872","relation":{},"ISSN":["1556-3316","1556-3324"],"issn-type":[{"value":"1556-3316","type":"print"},{"value":"1556-3324","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]}}}